Immunogenicity and Safety of a Booster Dose of an Investigational Adjuvanted Polyprotein HIV-1 Vaccine in Healthy Adults and Effect of Administration of Chloroquine
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunogenicity and Safety of a Booster Dose of an Investigational Adjuvanted Polyprotein HIV-1 Vaccine in Healthy Adults and Effect of Administration of Chloroquine
Authors
Keywords
-
Journal
Clinical and Vaccine Immunology
Volume 21, Issue 3, Pages 302-311
Publisher
American Society for Microbiology
Online
2014-01-04
DOI
10.1128/cvi.00617-13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune interventions in HIV infection
- (2013) Guislaine Carcelain et al. IMMUNOLOGICAL REVIEWS
- Harnessing CD4+ T cell responses in HIV vaccine development
- (2013) Hendrik Streeck et al. NATURE MEDICINE
- Enhancement of T cell-mediated immune responses to whole inactivated influenza virus by chloroquine treatment in vivo
- (2013) Bruno Garulli et al. VACCINE
- Polyfunctional CD4+ T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine
- (2013) Eva Van Braeckel et al. VACCINE
- Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: A randomised placebo-controlled study
- (2013) Thomas Harrer et al. VACCINE
- Beyond Empiricism: Informing Vaccine Development through Innate Immunity Research
- (2012) Stuart M. Levitz et al. CELL
- HIV vaccines
- (2012) Eva Van Braeckel et al. Human Vaccines & Immunotherapeutics
- Dissecting the T Cell Response: Proliferation Assays vs. Cytokine Signatures by ELISPOT
- (2012) Donald D. Anthony et al. Cells
- An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4+ T Cell Responses in Seronegative Volunteers
- (2011) Eva Van Braeckel et al. CLINICAL INFECTIOUS DISEASES
- Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
- (2011) Nathalie Garçon et al. Expert Review of Vaccines
- Induction of Strong HIV-1–Specific CD4+ T-Cell Responses Using an HIV-1 gp120/NefTat Vaccine Adjuvanted With AS02A in Antiretroviral-Treated HIV-1–Infected Individuals
- (2011) Mathias Lichterfeld et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Vaccine-induced HIV seropositivity: A problem on the rise
- (2011) Eva Van Braeckel et al. JOURNAL OF CLINICAL VIROLOGY
- CD8 T-Cell Proliferative Capacity Is Compromised in Primary HIV-1 Infection
- (2010) Sonya L Heath et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems
- (2010) Isabel Leroux-Roels et al. VACCINE
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- Primary CD8+ T-Cell Response to Soluble Ovalbumin Is Improved by Chloroquine Treatment In Vivo
- (2008) B. Garulli et al. Clinical and Vaccine Immunology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now